intervention

URI: https://gptkb.org/prop/intervention

181 triples

GPTKB property

interventionModel • interventionType • keyInterventions • mainIntervention

Subject	Object
gptkb:NCT03830207	gptkb:PF-07321332
gptkb:A_Randomized,_Double-blind,_Parallel-group,_Placebo-controlled,_Phase_2_Study_to_Evaluate_the_Efficacy_and_Safety_of_Benralizumab_in_Patients_With_Uncontrolled_Asthma	gptkb:Benralizumab
gptkb:Diabetes_Prevention_Program	lifestyle modification
gptkb:NCT04513366	gptkb:Placebo
gptkb:Heart_Protection_Study	antioxidant vitamins
gptkb:NCT03888612	gptkb:Ritonavir
gptkb:LipiDiDiet_study	gptkb:Fortasyn_Connect
gptkb:ALTTO_trial	gptkb:lapatinib
gptkb:NCT03830207	gptkb:Ritonavir
gptkb:NCT04072952	Tirzepatide
gptkb:CORIVRON_4	gptkb:Remdesivir
gptkb:NCT04513366	Parallel Assignment
gptkb:Relating_Clinical_Outcomes_in_Multiple_Myeloma_to_Personal_Assessment_of_Genetic_Profile_Study	genetic profiling
gptkb:SURPASS-1	tirzepatide 15 mg
gptkb:NCT04072952	gptkb:Placebo
gptkb:NCT02477826	gptkb:Pembrolizumab
gptkb:Malaria_Consortium's_Seasonal_Malaria_Chemoprevention_program	seasonal malaria chemoprevention
gptkb:Heart_Protection_Study	gptkb:simvastatin
gptkb:PARADIGM-HF	gptkb:enalapril
gptkb:A_Study_of_Donanemab_(LY3002813)_in_Participants_With_Preclinical_Alzheimer’s_Disease_(TRAILBLAZER-ALZ_3)	Donanemab (LY3002813)